Cargando…
Immune checkpoints in thymic epithelial tumors: challenges and opportunities
Thymic malignancies are rare mediastinal cancers, classified according to the World Health Organization's histopathologic classification which distinguishes thymomas from thymic carcinomas. One key consideration when discussing immunotherapy for thymic epithelial tumors is that one-third of pat...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216246/ https://www.ncbi.nlm.nih.gov/pubmed/35757304 http://dx.doi.org/10.1016/j.iotech.2019.09.002 |